Acerus Pharmaceuticals Corporation News - ASP

FeaturedSouthern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project

Acerus Announces Voting Results for the 2022 Annual Meeting

TORONTO, June 27, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus”) (TSX: ASP; OTCQB:...

Acerus Announces Amendments to Loan Facility

TORONTO, June 24, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”...

Acerus Announces Amendment and Restatement of the Promissory Note Related to the Up-Front Fee Payable to Former Serenity Securityholders

TORONTO, June 07, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”...

Acerus Reports First Quarter 2022 Financial Results

TORONTO, May 10, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”...

Acerus To Report Q1-2022 Financial Results And Host Investor Call

TORONTO, May 05, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCD) will...

Acerus Announces Completion of Share Consolidation

TORONTO, April 26, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”...

Acerus Announces Share Consolidation

TORONTO, April 19, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”...

Acerus Announces Amendments to Loan Facility

TORONTO, March 31, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”...

Acerus Reports Fourth Quarter and Full Year 2021 Financial Results

TORONTO, March 15, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”...

Acerus To Report Q4 And Full Year 2021 Financial Results And Host Investor Call

TORONTO, March 10, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will...

Acerus Announces Closing of Acquisition of Serenity Pharmaceuticals LLC and Acquisition of Global Rights to Noctiva™

TORONTO, March 07, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”...

Acerus Announces Definitive Agreement to Acquire Serenity LLC and the Global Rights to Noctiva™

Creating a Leading Urology & Men’s Health Pharmaceutical Company Acerus to have access to two significant...

Acerus Announces Amendment to Loan Facilities

TORONTO, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”...

Acerus Pharmaceuticals Announces Commercial Agreement With Verity Pharmaceuticals for the Promotion of NATESTO® in Puerto Rico

Verity Pharmaceuticals will begin promoting NATESTO to health care professionals throughout Puerto Rico in Q1...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Acerus Pharmaceuticals Corporation (ASP)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

ASP News

FeaturedSouthern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project

Acerus Announces Voting Results for the 2022 Annual Meeting

Acerus Announces Amendments to Loan Facility

Acerus Announces Amendment and Restatement of the Promissory Note Related to the Up-Front Fee Payable to Former Serenity Securityholders

Acerus Reports First Quarter 2022 Financial Results

Acerus To Report Q1-2022 Financial Results And Host Investor Call

Acerus Announces Completion of Share Consolidation

Acerus Announces Share Consolidation

Acerus Announces Amendments to Loan Facility

Acerus Reports Fourth Quarter and Full Year 2021 Financial Results

Acerus To Report Q4 And Full Year 2021 Financial Results And Host Investor Call

Acerus Announces Closing of Acquisition of Serenity Pharmaceuticals LLC and Acquisition of Global Rights to Noctiva™

Acerus Announces Definitive Agreement to Acquire Serenity LLC and the Global Rights to Noctiva™

Acerus Announces Amendment to Loan Facilities

Acerus Pharmaceuticals Announces Commercial Agreement With Verity Pharmaceuticals for the Promotion of NATESTO® in Puerto Rico

ASP Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Acerus Pharmaceuticals Corporation (ASP) News

Acerus Pharmaceuticals Corporation (ASP)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

ASP News

FeaturedSouthern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project

Acerus Announces Voting Results for the 2022 Annual Meeting

Acerus Announces Amendments to Loan Facility

Acerus Announces Amendment and Restatement of the Promissory Note Related to the Up-Front Fee Payable to Former Serenity Securityholders

Acerus Reports First Quarter 2022 Financial Results

Acerus To Report Q1-2022 Financial Results And Host Investor Call

Acerus Announces Completion of Share Consolidation

Acerus Announces Share Consolidation

Acerus Announces Amendments to Loan Facility

Acerus Reports Fourth Quarter and Full Year 2021 Financial Results

Acerus To Report Q4 And Full Year 2021 Financial Results And Host Investor Call

Acerus Announces Closing of Acquisition of Serenity Pharmaceuticals LLC and Acquisition of Global Rights to Noctiva™

Acerus Announces Definitive Agreement to Acquire Serenity LLC and the Global Rights to Noctiva™

Acerus Announces Amendment to Loan Facilities

Acerus Pharmaceuticals Announces Commercial Agreement With Verity Pharmaceuticals for the Promotion of NATESTO® in Puerto Rico

ASP Discussion

Your Recent History